Zobrazeno 1 - 10
of 61
pro vyhledávání: '"J. E. Norman"'
Autor:
V. Flenady, G. Gardener, F. M. Boyle, E. Callander, M. Coory, C. East, D. Ellwood, A. Gordon, K. M. Groom, P. F. Middleton, J. E. Norman, K. A. Warrilow, M. Weller, A. M. Wojcieszek, C. Crowther, on behalf of the IMPACT Clinical Trials Network for Mothers’ and Babies’ Health
Publikováno v:
BMC Pregnancy and Childbirth, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Stillbirth is a devastating pregnancy outcome that has a profound and lasting impact on women and families. Globally, there are over 2.6 million stillbirths annually and progress in reducing these deaths has been slow. Maternal pe
Externí odkaz:
https://doaj.org/article/4aac99cfb1f24fbf8667748e7760755c
Publikováno v:
BMC Medical Ethics, Vol 18, Iss 1, Pp 1-13 (2017)
Abstract Background Obtaining prospective written consent from women to participate in trials when they are experiencing an obstetric emergency is challenging. Alternative consent pathways, such as gaining verbal consent at enrolment followed, later,
Externí odkaz:
https://doaj.org/article/3567419c5a14428487128e60193c7e61
Publikováno v:
Molecular Human Reproduction
STUDY QUESTION Is labour, both at term and preterm, associated with alterations in decidual lymphocyte densities and widespread changes to the decidual transcriptome? SUMMARY ANSWER The onset of parturition, both at term and preterm, is associated wi
Publikováno v:
Molecular Human Reproduction
Both term and preterm parturition are characterized by an influx of macrophages and neutrophils into the myometrium and cervix, with co-incident increased peripheral blood monocyte activation. Infection and inflammation are strongly implicated in the
Publikováno v:
Molecular Human Reproduction
Preterm birth remains the leading cause of neonatal mortality and morbidity worldwide. There are currently few effective therapies and therefore an urgent need for novel treatments. Although there is much focus on trying to alter gestation of deliver
Autor:
Jan Liliemark, Jonas Wallvik, Devinder Gill, Stephen P. Mulligan, Bertil Uggla, Gunnar Juliusson, Viggo Jønsson, Mark Hertzberg, J. E. Norman, Karin Karlsson, Mats Strömberg, Roger McLennan, Gunnel Sundström, Jens Hammerstrøm, Yvonne Brandberg, Hemming Johansson
Publikováno v:
Leukemialymphoma. 55(12)
We conducted a randomized phase III trial to compare the efficacy and safety of two purine analogs, cladribine and fludarabine, with high-dose chlorambucil, in patients with previously untreated chronic lymphocytic leukemia (CLL). Between 1997 and 20
Autor:
J E Norman
Publikováno v:
Geburtshilfe und Frauenheilkunde. 76:1205-1205
Autor:
R Herrmann, P Cannell, A Grigg, B. M. Dale, K Atkinson, Jeff Szer, David D.F. Ma, Timothy P. Hughes, J Ho, J E Norman, A P Schwarer, KM Taylor, R. E. Sage, Green Rm, C Arthur
Publikováno v:
British Journal of Haematology. 96:635-640
Mobilization of Philadelphia chromosome (Ph) negative blood progenitors was attempted in 23 newly diagnosed chronic myeloid leukaemia (CML) patients using a regimen of cyclophosphamide (CY) 5 g/m 2 and rHUG-CSF 1150 μg/m 2 daily. This regimen was we
Autor:
Alexander Dobrovic, R. E. Sage, A. Bolton, J X Mi, J. E. Norman, Jennifer E. Hardingham, B.M. Dale, L T Gooley, Dusan Kotasek
Publikováno v:
Journal of Clinical Oncology. 13:1073-1079
PURPOSE To evaluate the significance of molecular marker-positive cells in a cohort of non-Hodgkin's lymphoma (NHL) patients undergoing high-dose chemotherapy and autologous peripheral-blood stem-cell transplantation (PBSCT). PATIENTS AND METHODS Twe
Publikováno v:
PlantwisePlus Knowledge Bank.